Roger M Perlmutter Merck & Co., Inc. (MRK) insider trading activity

Roger M Perlmutter is Exe V-P & Pres, MRL of Merck & Co., Inc.. Currently has a direct ownership of 214,428 shares of MRK, which is worth approximately $21 Million. The most recent transaction as insider was on Feb 28, 2020, when has been sold 35,049 shares (Common Stock) at a price of $76.56 per share, resulting in proceeds of $2,683,351. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 214K

0% 3M change

0% 12M change

Total Value Held $21 Million

ROGER M PERLMUTTER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2020	BUY Grant, award, or other acquisition	$2,683,351 $76.56 p/Share	35,049 Added 14.05%	214,428 Common Stock
Feb 25 2019	BUY Grant, award, or other acquisition	$2,647,476 $80.38 p/Share	32,937 Added 15.81%	175,335 Common Stock
Nov 08 2018	SELL Open market or private sale	$16,969,094 $75.27 p/Share	225,443 Reduced 61.43%	141,554 Common Stock
Nov 08 2018	BUY Exercise of conversion of derivative security	$10,140,426 $44.98 p/Share	225,443 Added 38.05%	366,997 Common Stock
Feb 27 2018	BUY Grant, award, or other acquisition	$1,911,424 $54.72 p/Share	34,931 Added 20.09%	138,906 Common Stock
Feb 27 2017	BUY Grant, award, or other acquisition	$2,151,319 $65.85 p/Share	32,670 Added 24.33%	101,601 Common Stock
May 06 2016	SELL Payment of exercise price or tax liability	$1,457,509 $54.09 p/Share	26,946 Reduced 28.39%	67,953 Common Stock
May 06 2016	BUY Exercise of conversion of derivative security	-	44,464 Added 31.91%	94,899 Common Stock
Feb 22 2016	BUY Grant, award, or other acquisition	$1,280,775 $50.77 p/Share	25,227 Added 33.43%	50,227 Common Stock

Also insider at

NGM

NGM BIOPHARMACEUTICALS INC Healthcare

RMP